Bristol-Myers Squibb Rights
CELG.RT
18 hedge funds and large institutions have $4.17M invested in Bristol-Myers Squibb Rights in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
10% less funds holding
Funds holding: 20 → 18 (-2)
23% less capital invested
Capital invested by funds: $5.44M → $4.17M (-$1.27M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.34K |
| 2 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$1.13K |
| 2 |
TPA
Trivium Point Advisory
Westport,
Connecticut
|
-$550 |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$7 |
CELG.RT Hedge Fund Activity: Q2 2024 in Review
18 of the 6,927 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q2 2024, worth a combined $4.17M — down 23% from $5.44M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CELG.RT and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Susquehanna International Group, adding an estimated $2.34K. The largest seller was CAPTRUST Financial Advisors, exiting entirely with an estimated $1.13K sold.
- 18 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q2 2024, down from 20 in Q1 2024.
- Funds reported $4.17M of Bristol-Myers Squibb Rights stock for Q2 2024, down 23% quarter-over-quarter.
- 0 funds opened new Bristol-Myers Squibb Rights positions in Q2 2024 and 2 closed out, a net change of -2 holders.
- The largest Bristol-Myers Squibb Rights buyer in Q2 2024 was Susquehanna International Group, an estimated $2.34K added.
- The largest Bristol-Myers Squibb Rights seller in Q2 2024 was CAPTRUST Financial Advisors, an estimated $1.13K sold.
Based on aggregated 13F filings for Q2 2024.